-
Symbol
-
ANTX on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.00001 par value per share
-
Latest Disclosed Ownership
-
5.75M shares
-
Security Ownership
-
19.2%
BML Investment Partners, L.P. ownership in AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX)
2025-02-13 - BML Investment Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.75M shares of AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX).
This represents 19.2% percent ownership of the company.